BEONE MEDICINES LTD-ADR (ONC) Stock Fundamental Analysis

NASDAQ:ONC • US07725L1026

318.61 USD
-33.62 (-9.54%)
Last: Feb 26, 2026, 01:32 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Overall ONC gets a fundamental rating of 5 out of 10. We evaluated ONC against 521 industry peers in the Biotechnology industry. ONC has an average financial health and profitability rating. ONC is growing strongly while it also seems undervalued. This is an interesting combination With these ratings, ONC could be worth investigating further for value and growth investing!.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year ONC was profitable.
  • In the past year ONC had a positive cash flow from operations.
  • ONC had negative earnings in each of the past 5 years.
  • ONC had a negative operating cash flow in each of the past 5 years.
ONC Yearly Net Income VS EBIT VS OCF VS FCFONC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -2B -4B -6B -8B -10B

1.2 Ratios

  • The Return On Assets of ONC (-0.28%) is better than 87.91% of its industry peers.
  • Looking at the Return On Equity, with a value of -0.52%, ONC belongs to the top of the industry, outperforming 89.44% of the companies in the same industry.
  • ONC has a better Return On Invested Capital (1.88%) than 89.44% of its industry peers.
Industry RankSector Rank
ROA -0.28%
ROE -0.52%
ROIC 1.88%
ROA(3y)-19.6%
ROA(5y)-21.52%
ROE(3y)-30.77%
ROE(5y)-32.33%
ROIC(3y)N/A
ROIC(5y)N/A
ONC Yearly ROA, ROE, ROICONC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

  • The Operating Margin of ONC (2.86%) is better than 89.25% of its industry peers.
  • The Gross Margin of ONC (85.99%) is better than 88.48% of its industry peers.
  • ONC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.86%
PM (TTM) N/A
GM 85.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.66%
GM growth 5Y0.23%
ONC Yearly Profit, Operating, Gross MarginsONC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • ONC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • ONC has more shares outstanding than it did 1 year ago.
  • ONC has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ONC is higher compared to a year ago.
ONC Yearly Shares OutstandingONC Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ONC Yearly Total Debt VS Total AssetsONC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

  • An Altman-Z score of 6.14 indicates that ONC is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 6.14, ONC is doing good in the industry, outperforming 73.70% of the companies in the same industry.
  • The Debt to FCF ratio of ONC is 2.51, which is a good value as it means it would take ONC, 2.51 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of ONC (2.51) is better than 92.90% of its industry peers.
  • A Debt/Equity ratio of 0.23 indicates that ONC is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.23, ONC is not doing good in the industry: 66.03% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 2.51
Altman-Z 6.14
ROIC/WACC0.39
WACC4.8%
ONC Yearly LT Debt VS Equity VS FCFONC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B 30B

2.3 Liquidity

  • A Current Ratio of 2.40 indicates that ONC has no problem at all paying its short term obligations.
  • ONC's Current ratio of 2.40 is on the low side compared to the rest of the industry. ONC is outperformed by 71.98% of its industry peers.
  • A Quick Ratio of 2.17 indicates that ONC has no problem at all paying its short term obligations.
  • With a Quick ratio value of 2.17, ONC is not doing good in the industry: 72.55% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.4
Quick Ratio 2.17
ONC Yearly Current Assets VS Current LiabilitesONC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • ONC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 215.42%, which is quite impressive.
  • Looking at the last year, ONC shows a very strong growth in Revenue. The Revenue has grown by 50.62%.
  • ONC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 55.91% yearly.
EPS 1Y (TTM)215.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%188.84%
Revenue 1Y (TTM)50.62%
Revenue growth 3Y53.06%
Revenue growth 5Y55.91%
Sales Q2Q%40.84%

3.2 Future

  • ONC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 98.42% yearly.
  • ONC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.94% yearly.
EPS Next Y146.71%
EPS Next 2Y71.19%
EPS Next 3Y49.35%
EPS Next 5Y98.42%
Revenue Next Year42.03%
Revenue Next 2Y31.62%
Revenue Next 3Y26%
Revenue Next 5Y18.94%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ONC Yearly Revenue VS EstimatesONC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 20B 40B 60B 80B
ONC Yearly EPS VS EstimatesONC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1K 2K 3K

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • ONC is valuated cheaply with a Price/Earnings ratio of 4.84.
  • Based on the Price/Earnings ratio, ONC is valued cheaply inside the industry as 99.42% of the companies are valued more expensively.
  • ONC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.05.
  • The Price/Forward Earnings ratio is 46.60, which means the current valuation is very expensive for ONC.
  • Based on the Price/Forward Earnings ratio, ONC is valued cheaply inside the industry as 89.83% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 28.03. ONC is valued rather expensively when compared to this.
Industry RankSector Rank
PE 4.84
Fwd PE 46.6
ONC Price Earnings VS Forward Price EarningsONC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, ONC is valued cheaper than 92.13% of the companies in the same industry.
Industry RankSector Rank
P/FCF 72.98
EV/EBITDA N/A
ONC Per share dataONC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • ONC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ONC's earnings are expected to grow with 49.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y71.19%
EPS Next 3Y49.35%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ONC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BEONE MEDICINES LTD-ADR

NASDAQ:ONC (2/26/2026, 1:32:04 PM)

318.61

-33.62 (-9.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06
Earnings (Next)02-26
Inst Owners42.98%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change-4.61%
Market Cap35.26B
Revenue(TTM)35.67B
Net Income(TTM)-153.00M
Analysts82.67
Price Target365.13 (14.6%)
Short Float %17.23%
Short Ratio5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.56
Dividend Growth(5Y)N/A
DP-360.44%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)590.84%
Min EPS beat(2)-5.45%
Max EPS beat(2)1187.13%
EPS beat(4)3
Avg EPS beat(4)1523.03%
Min EPS beat(4)-5.45%
Max EPS beat(4)3109.85%
EPS beat(8)3
Avg EPS beat(8)516.07%
EPS beat(12)4
Avg EPS beat(12)343.82%
EPS beat(16)5
Avg EPS beat(16)253.79%
Revenue beat(2)1
Avg Revenue beat(2)2.46%
Min Revenue beat(2)-1.36%
Max Revenue beat(2)6.29%
Revenue beat(4)2
Avg Revenue beat(4)2.29%
Min Revenue beat(4)-1.36%
Max Revenue beat(4)6.29%
Revenue beat(8)6
Avg Revenue beat(8)8.35%
Revenue beat(12)10
Avg Revenue beat(12)12.39%
Revenue beat(16)13
Avg Revenue beat(16)10.75%
PT rev (1m)5.01%
PT rev (3m)-4.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.89%
EPS NY rev (1m)0%
EPS NY rev (3m)63.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.49%
Revenue NY rev (3m)1.26%
Valuation
Industry RankSector Rank
PE 4.84
Fwd PE 46.6
P/S 6.79
P/FCF 72.98
P/OCF 49.79
P/B 8.26
P/tB 8.62
EV/EBITDA N/A
EPS(TTM)65.79
EY20.65%
EPS(NY)6.84
Fwd EY2.15%
FCF(TTM)4.37
FCFY1.37%
OCF(TTM)6.4
OCFY2.01%
SpS46.93
BVpS38.59
TBVpS36.97
PEG (NY)0.03
PEG (5Y)N/A
Graham Number239.01
Profitability
Industry RankSector Rank
ROA -0.28%
ROE -0.52%
ROCE 2.73%
ROIC 1.88%
ROICexc 5.89%
ROICexgc 6.47%
OM 2.86%
PM (TTM) N/A
GM 85.99%
FCFM 9.3%
ROA(3y)-19.6%
ROA(5y)-21.52%
ROE(3y)-30.77%
ROE(5y)-32.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.66%
GM growth 5Y0.23%
F-Score7
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 2.51
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 4.33%
Interest Coverage 250
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.4
Quick Ratio 2.17
Altman-Z 6.14
F-Score7
WACC4.8%
ROIC/WACC0.39
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)20.18%
Cap/Sales(5y)27.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)215.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%188.84%
EPS Next Y146.71%
EPS Next 2Y71.19%
EPS Next 3Y49.35%
EPS Next 5Y98.42%
Revenue 1Y (TTM)50.62%
Revenue growth 3Y53.06%
Revenue growth 5Y55.91%
Sales Q2Q%40.84%
Revenue Next Year42.03%
Revenue Next 2Y31.62%
Revenue Next 3Y26%
Revenue Next 5Y18.94%
EBIT growth 1Y115.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year206.46%
EBIT Next 3Y69.73%
EBIT Next 5Y60.32%
FCF growth 1Y131.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y172.14%
OCF growth 3YN/A
OCF growth 5YN/A

BEONE MEDICINES LTD-ADR / ONC FAQ

What is the ChartMill fundamental rating of BEONE MEDICINES LTD-ADR (ONC) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ONC.


What is the valuation status for ONC stock?

ChartMill assigns a valuation rating of 7 / 10 to BEONE MEDICINES LTD-ADR (ONC). This can be considered as Undervalued.


How profitable is BEONE MEDICINES LTD-ADR (ONC) stock?

BEONE MEDICINES LTD-ADR (ONC) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for ONC stock?

The Price/Earnings (PE) ratio for BEONE MEDICINES LTD-ADR (ONC) is 4.84 and the Price/Book (PB) ratio is 8.26.


Can you provide the dividend sustainability for ONC stock?

The dividend rating of BEONE MEDICINES LTD-ADR (ONC) is 0 / 10 and the dividend payout ratio is -360.44%.